tiprankstipranks
Trending News
More News >
Q32 Bio (QTTB)
NASDAQ:QTTB
US Market

Q32 Bio (QTTB) Financial Statements

Compare
901 Followers

Q32 Bio Financial Overview

Q32 Bio's market cap is currently $47.74M. The company's EPS TTM is $-0.6; its P/E ratio is -1.12; Q32 Bio is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.97. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ -6.65M$ 6.65M$ 33.97M$ 2.70M
Gross Profit$ -487.00K$ -6.65M$ 6.65M$ 24.43M$ 2.70M
Operating Income$ -66.10M$ -48.26M$ -39.23M$ -95.95M$ -130.26M
EBITDA$ -45.30M$ -47.76M$ -38.85M$ -86.22M$ -119.79M
Net Income$ -47.73M$ -53.74M$ -42.81M$ -95.76M$ -128.69M
Balance Sheet
Cash & Short-Term Investments$ 77.97M$ 25.62M$ 43.89M$ 155.87M$ 217.43M
Total Assets$ 92.33M$ 47.06M$ 61.77M$ 211.72M$ 263.74M
Total Debt$ 18.90M$ 50.84M$ 44.73M$ 23.93M$ 15.44M
Net Debt$ -59.06M$ 25.22M$ 838.00K$ -84.45M$ -201.99M
Total Liabilities$ 86.66M$ 229.98M$ 192.49M$ 42.07M$ 67.74M
Stockholders' Equity$ 5.67M$ -182.92M$ -130.71M$ 169.65M$ 196.00M
Cash Flow
Free Cash Flow$ -67.79M$ -18.68M$ -13.44M$ -112.15M$ -98.06M
Operating Cash Flow$ -67.72M$ -18.68M$ -10.96M$ -109.75M$ -94.33M
Investing Cash Flow$ 19.93M$ -5.00K$ -2.47M$ -50.79M$ 204.90M
Financing Cash Flow$ 95.14M$ 406.00K$ 30.07M$ 52.17M$ 53.09M
Currency in USD

Q32 Bio Earnings and Revenue History

Q32 Bio Debt to Assets

Q32 Bio Cash Flow

Q32 Bio Forecast EPS vs Actual EPS